← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2005Last known activity
Jul 1, 2016
Timeline
2000s
- Jun 1, 2002
Provectus Biopharmaceuticals, Inc.— Founded
Drugs by trial phase (7 distinct, 14 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT02693067Study directorPhase 1Jul 1, 2016
- NCT02693067Lead sponsorPhase 1Jul 1, 2016
- NCT02557321Study directorPhase 1/Phase 2Oct 1, 2015
- NCT02557321Lead sponsorPhase 1/Phase 2Oct 1, 2015
- NCT02288897Lead sponsorPhase 3Apr 1, 2015
- NCT02288897Study directorPhase 3Apr 1, 2015
- NCT02322086Lead sponsorPhase 2Jan 1, 2015
- NCT02322086Study directorPhase 2Jan 1, 2015
- NCT01760499CollaboratorPhase 1Jan 24, 2013
- NCT01260779Lead sponsorN/ADec 13, 2010
- NCT01247818Study directorPhase 2Dec 1, 2010
- NCT01247818Lead sponsorPhase 2Dec 1, 2010
- NCT00986661Lead sponsorPhase 1Oct 1, 2009
- NCT00986661Study directorPhase 1Oct 1, 2009
- NCT00941278Study directorPhase 2Jul 1, 2009
Details
- Founded
- Knoxville, TN, US Jun 1, 2002
- Last known activity
- Jul 1, 2016